Silver Book Fact

The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.

Alzheimer's Association. 2012 Alzheimer’s Disease Facts and Figures. Alzheimers Dement. 2012; 8(2): 131-68. http://www.alzheimersanddementia.com/article/S1552-5260(12)00032-5/fulltext

Reference

Title
2012 Alzheimer’s Disease Facts and Figures
Publication
Alzheimers Dement
Publication Date
2012
Authors
Alzheimer's Association
Volume & Issue
Volume 8, Issue 2
Pages
131-68
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 out-of-pocket costs to individuals and families dealing with the…  
  • Galantamine, a cholinesterase inhibitor, delays Alzheimer’s patients’ need for full-time care, with overall cost savings estimated between $323 and $4,256 per patient.  
  • A study of rasagiline mesylate in Parkinson’s disease patients showed improved motor fluctuations and other Parkinson’s disease symptoms.  
  • A recent study showed that memantine, a medicine approved to treat moderate-to-severe Alzheimer’s, significantly slows cognitive decline and reduces the need for caregiving by 45.8 hours per month.